<DOC>
	<DOCNO>NCT02062853</DOCNO>
	<brief_summary>The primary aim study evaluate effect prospective patient education patient satisfaction administration topical 5 % 5-fluorouracil cream treatment actinic keratosis involve face , scalp , upper chest , dorsal hand forearm . Specifically , study aim determine prospective patient view educational video delineate treatment effect expectation improve patient satisfaction treatment completion rate .</brief_summary>
	<brief_title>Continuous Quality Improvement ( CQI ) Pilot Study Evaluating Utility Educational Video</brief_title>
	<detailed_description />
	<mesh_term>Keratosis</mesh_term>
	<mesh_term>Keratosis , Actinic</mesh_term>
	<criteria>Subjects clinical diagnosis actinic keratoses least 6 clinicallydiagnosed actinic keratoses face , bald scalp , arm , upper chest , OR dorsal hand classify grade I , mild ( slightly palpable actinic keratoses , easily felt see ) , II , moderate ( moderately thick hyperkeratotic actinic keratoses , easily felt ) . Patients use interferon interferon inducer , immunomodulators , cytotoxic immunosuppressor drug , corticosteroid , retinoids , investigational drug within 4 week prior enrollment . Patients treated topical drug actinic keratoses lesion le 8 week prior enrollment . Patients invasive tumor within treated area ( e.g . invasive squamous cell carcinoma ) Patients exhibited dermatological disease within treat adjacent ( 3 cm distance ) area time screen . Patients known allergy fluorouracil ( 5FU ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>